News

April 19, 2016April 19, 2016

P. Aeruginosa in Cystic Fibrosis Can Be Eliminated with AmpliPhi’s Bacteriophage Candidate, According to Data

Cystic Fibrosis, News

AmpliPhi Biosciences Corporation, a biotech company dedicated to the development of novel bacteriophage-based antibacterial therapies, recently presented new clinical data regarding its proprietary investigational phage mix AB-PA01’s in vitro and ... Read more

April 18, 2016April 19, 2016

Karos Pharmaceuticals Advances PAH Drug Candidate into the Clinic

News, Pulmonary Hypertension

Karos Pharmaceuticals recently announced it has advanced its small molecule investigational drug candidate, KAR5585, into the clinic for the treatment of pulmonary arterial hypertension (PAH) and other rare conditions marked ... Read more

April 18, 2016April 19, 2016

FDA Approves Corbus Phase 2 Trial Extension of Systemic Sclerosis Drug Resunab

News, Scleroderma

Corbus Pharmaceuticals, a clinical stage company targeting rare, chronic inflammatory and fibrotic diseases, recently received approval by the U.S. Food and Drug Administration (FDA) for a 12-month open-label extension trial ... Read more

April 15, 2016April 18, 2016

New Lung Transplant Program Opens at Memorial Hermann in Houston

COPD, Cystic Fibrosis, News, Pulmonary Hypertension

Memorial Hermann-Texas Medical Center (TMC) recently announced its new Lung Transplant Program, which offers lung and all solid organ transplants, including the kidney, liver, and heart. The Centers for Disease Control and Prevention ... Read more

April 15, 2016April 15, 2016

Antimicrobial Agent Targeting Resistant CF Infections Named ‘Orphan Drug’ by FDA

Cystic Fibrosis, News

TGV-Inhalonix, Inc., recently announced that its drug candidate, the antimicrobial agent Mul-1867, has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of antibiotic-resistant bacterial ... Read more

April 15, 2016April 15, 2016

Cigarette Smoke and Flu Virus Decrease Effects of COPD Medication, According to Study

COPD, News

The effectiveness of salbutamol, a medication used to relieve the symptoms of chronic obstructive pulmonary disease (COPD), is reduced when patients are exposed to cigarette smoke and influenza A infection in ... Read more

April 14, 2016April 14, 2016

Phase 3 Trial of Brigatinib for Non-Small Cell Lung Cancer Linked to ALK Mutations Is Launched by ARIAD

Lung Cancer, News

ARIAD Pharmaceuticals recently announced the start of a Phase 3 clinical trial of brigatinib for locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults with mutations in the anaplastic ... Read more

April 14, 2016April 14, 2016

Lungs of Children Exposed to Air Pollution Show Diminished Function, Study Reports

News

Air quality in U.S. cities has dramatically improved since the 1990s, but not enough to ensure that children’s lungs are not being damaged by pollution, according to a study in the American ... Read more

April 14, 2016April 19, 2016

Study Reports Unrecognized Pulmonary Hypertension in Pulmonary Embolism Patients

News, Pulmonary embolism, Pulmonary Hypertension

A retrospective study sponsored by Bayer suggested that many patients who suffered from pulmonary embolism have a higher risk of developing chronic thromboembolic pulmonary hypertension (CTEPH), a life-threatening form of pulmonary ... Read more

April 13, 2016April 13, 2016

Eating Salmon During Pregnancy May Reduce Asthma Risk in Child, According to Study

Asthma, News

Eating salmon during pregnancy may reduce the chance of a child being diagnosed with asthma, compared to children whose mothers did not eat the oily fish, according to recent research. ... Read more